Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is xyAid's primary technological focus?
- xyAid develops a method of ultrasonic separation between normal and abnormal spermatozoa, based on their different morphological structures and concentrations.
- What is the purpose of xyAid's UV treatment in its technology?
- The UV treatment used by xyAid substantially enriches the fraction of normal cells, which aims to increase fertility and assist with cell reproduction.
- What applications does xyAid's Assisted Reproduction Technologies (ART) target?
- xyAid's technology is relevant for intrauterine insemination, in-vitro fertilization, and intracytoplasmic sperm injection.
- When was xyAid founded?
- xyAid was founded in January 2015.
- What is the current operational status of xyAid?
- xyAid is currently inactive, as of January 2018.
- Where is xyAid headquartered?
- xyAid is headquartered in Jerusalem, Israel.
- How many employees does xyAid have?
- xyAid has between 1 and 10 employees, with an exact count of 6.
- What is xyAid's current funding stage?
- xyAid is currently in the Pre-Funding stage.
- Who are the co-founders of xyAid?
- The co-founders of xyAid are Zachariah Gershon and Abba Priev, PhD.
- Does xyAid hold any patents?
- Yes, xyAid holds 1 patent.